A recent report suggested that female recipients of male deceased-donor kidneys are at increased risk for graft failure because of H-Y antigen mismatch. In an attempt to confirm and extend these results, we studied all adult recipients of deceased-donor kidney transplants from 1990 through 2004 in the US Renal Data System. Compared with all other gender combinations, female recipients of male donor kidneys had a 12% increased risk for graft failure at 1 yr (hazard ratio 1.12; 95% confidence interval 1.05 to 1.19) but no excess risk at 10 yr (hazard ratio 1.03; 95% confidence interval 0.98 to 1.07). We observed a similar pattern of short-and long-term risk for both death-censored graft failure and mortality. The main results were consistent across several prespecified patient subgroups and were robust to sensitivity analyses. In conclusion, compared with other recipient-donor gender combinations, female recipients of male donor kidney transplants in the United States have an increased short-term risk but not long-term risk for adverse outcomes.
Allorecognition of human major histocompatibility antigens (i.e., HLA) and the associated immune response has important short-and long-term implications for successful kidney transplantation. Although much effort has been placed on trying to understand and control the immune response to these major histocompatibility antigens, relatively little is known about the role of minor histocompatibility antigens as determinants of outcome. H-Y antigens, derived from the Y chromosome, are a group of minor histocompatibility antigens that are widely expressed in human tissues 1 and have been found to be prognostically important for the survival of recipient-donor gender-mismatched hematopoietic stem cell transplants. [2] [3] [4] [5] [6] [7] [8] [9] Several studies of heart, lung, liver, and corneal transplantation have suggested that female recipients of male donor organs/tissues are at increased risk for adverse graft outcomes 10 -13 ; however, other studies have failed to show this effect. 14 -18 Recently, a report by Gratwohl et al., 19 using data from the Collaborative Transplant Study (CTS), suggested that, after adjustment for the independent effects of recipient and donor gender, female recipients of male deceased-donor kidney transplants (versus all other recipient-donor gender combinations) were significantly associated with a 6 to 8% increase in the risk for graft failure and a 10 to 11% increase in the risk for death-censored graft failure during 10-yr of follow-up. They termed this phenomenon the "H-Y effect"; however, only 18.6% of the patients in the study by Gratwohl et al. were from North America, and a previous report failed to show an H-Y effect in zero-mismatched, US living-donor kidney transplants. 20 In addition, the impact of adjusting for a more extensive set of covariates (including recipient and donor weight) was not assessed. Given their greater susceptibility to unmeasured or residual confounding (as compared with randomized, controlled trials), it is important to reproduce the results of observational studies in different patient populations from different data sources. 21 In an attempt to confirm the results of Gratwohl et al. and to determine the relevance of the H-Y effect in deceased-donor kidney transplants performed in the United States, we undertook a retrospective cohort study using data from the US Renal Data System (USRDS). We used a modeling strategy similar to that of Gratwohl et al. and then extended it to include additional covariate data, an evaluation of prespecified subgroups, and various sensitivity analyses.
RESULTS
The median follow-up time for graft failure and patient mortality were 4.16 and 5.45 yr, respectively. This resulted in 548,904 and 660,602 total person-years at risk for graft failure and patient mortality, respectively. In total, there were 16,135 graft failures (6878 of which were deaths) during the first year of follow-up and 35,084 graft failures (22,566 of which were deaths) from the second to the 10th years of follow-up.
Baseline recipient, donor, and transplant characteristics across the four recipient-donor gender combinations are shown in Table 1 . Female recipients were more likely to be highly sensitized and have "other" causes of ESRD; however, there were no major differences in the distribution of other recipient characteristics. Female deceased donors tended to be white and older and had strokes as the most common cause of death. In light of the last two characteristics, a greater proportion of female kidneys were deemed expanded-criteria donors. Transplant characteristics, including the number of HLA mismatches, cold ischemia time, and transplant era, were similarly distributed across recipient-donor gender strata.
Figures 1 and 2 depict unadjusted Kaplan-Meier survival curves for the outcome of graft failure at 1 yr and 10 yr (conditioning on 1-yr survival), respectively, stratified by recipient-donor gender categories. At 1 yr, recipients of female deceased-donor kidneys had inferior survival to recipients of male deceased-donor kidneys, regardless of recipient gender. Conditional 10-yr event-free survival curves showed greater separation, with male recipients of female donors (RM-DF) having the lowest survival (43.1% at 10 yr) and female recipients of male donors (RF-DM) having the highest survival (49.3% at 10 yr). Interestingly, the outcomes of gender-concordant pairs (RF-DF and RM-DM) were highly comparable and intermediate relative to the other two groups (46.3 to 46.5% at 10 yr). A similar pattern was noted for death-censored graft failure and patient mortality (data not shown). Table 2 displays the results of multivariable Cox proportional hazards models for the three primary outcomes at 1 and 10 yr after transplantation. At both time points, female recipient gender was independently associated with a decreased risk for adverse graft and patient outcomes, whereas female donor gender exhibited the opposite pattern of association. After adjustment for these and other covariates, the RF-DM group showed a modest but significantly increased risk for graft failure and death-censored graft failure at 1 yr as compared with all other recipient-donor gender combinations (adjusted hazard ratio [HR] 1.12 [95% confidence interval (CI) 1.05 to 1.19] and 1.14 [95% CI 1.06 to 1.24], respectively); however, RF-DM status did not portend a significantly worse conditional graft or death-censored graft failure at 10 yr of follow-up (adjusted HR . The relative hazard of mortality was higher at 1 than 10 yr, but neither reached statistical significance. Table 3 shows the relative hazard for graft failure at 1 and 10 yr (conditional on 1-yr survival) for the RF-DM group (versus all others) across various prespecified patient subgroups. The association was similar to the main results or null at both time points for all categories of recipient race, donor race, and HLA mismatch, with no evidence of statistical interaction. Of note, recipient-donor pairs with zero HLA mismatches showed a similar relation between RF-DM and graft failure as the total study population. Although there was evidence of heterogeneity across HRs within categories of peak panel-reactive antibody (PRA) and cause of ESRD, there were no consistent patterns of association across these subgroups. The more recent eras of kidney transplantation showed a null effect of RF-DM versus all other recipient-donor gender combinations, but the test of interaction was only marginally significant at the 1-yr time point. Table 4 shows sensitivity analyses assessing the robustness of the primary results. The HR estimates did not materially change at either time point for most of the strategies used to reanalyze the data. Of note, the 10-yr graft and patient outcomes for scenario C incorporate the first year of follow-up, in which the risk has been shown to be the highest and thus exhibits significantly elevated HRs for the total follow-up.
DISCUSSION
This study revealed that, after adjustment for recipient and donor gender, RF-DM deceased-donor kidney transplants in the United States are associated with a modestly increased short-term (i.e., 1 yr) risk for adverse graft and patient outcomes as compared with all other recipient-donor gender combinations; however, RF-DM was not associated with a significant increase in the long-term (i.e., 10 yr) risk for graft failure and patient mortality. These findings were generally consistent across various patient subgroups and robust to several sensitivity analyses. Our short-term findings are consistent with Gratwohl et al., 19 who found that RF-DM had a significantly increased risk for graft failure and death-censored graft failure at 1 yr; however, unlike Gratwohl et al., we found no significantly increased risk during the 10-yr follow-up.
Minor histocompatibility antigens, including the protein products of H-Y, have been shown in murine models to be important in eliciting an immune response to the allograft, independent of HLA mismatches. [22] [23] [24] In human models, the importance of the H-Y effect has been most clearly demonstrated in hematopoietic stem cell transplantation. Female recipients exposed to H-Y antigens from male donors were more likely to experiences graft rejection, 2,3,9 whereas male recipients of female donors had a higher risk for graft-versus-host disease and graftversus-leukemia reaction. 4,6 -8 Although H-Y antigens are widely distributed in various human tissues, 1 the degree of expression of the H-Y peptide (which is relevant for the immune response) seems to vary as a function of the type of tissue. H-Y peptide expression seems to be highest in the cells of hematopoietic lineage. 25 This may account for the importance of the H-Y effect in the outcomes of hematopoietic stem cell transplantation. Interestingly, the expression of H-Y peptides was considerably lower in the kidney. 25 Some studies of nonkidney solid-organ transplants have shown a detrimental impact of the male donor-female recipient pairing on outcomes, 10 -13 but other reports have not confirmed these findings. 14 -18,26 Similar studies of kidney transplantation have ranged from single case reports to registry analyses. 2, 20, 27 Although there is evidence that H-Y antigens can cause acute rejection in RF-DM HLA-identical kidney transplants 27 and also lead to an H-Y antigen-specific antibody response, 28 the population-level impact of this phenomenon on graft and patient outcomes is uncertain. The study by Gratwohl et al. 19 is the first large-scale, epidemiologic analysis to suggest an H-Y effect (i.e., RF-DM deceased-donor kidney transplants) causes an increased risk for both short-and long-term graft failure and death-censored graft failure versus all other recipient-donor gender combinations. Our findings in US deceased-donor kidney transplant recipients suggest an elevated risk in the first year after transplantation but no detectable excess risk thereafter during 10 yr of follow-up. The reasons for the differences in long-term results may relate to the populations studied (including restrictions on entry into the study cohort) and variations in clinical practice patterns. Only 18.6% of the patients studied by Gratwohl et al. were from North America, with the vast majority of patients from Europe (69%). Although speculative, the degree of male donor to female recipient size mismatch may, on average, differ in the two continental populations, with US patients having a more favorable ratio. 29 -31 This overall size mismatch may not overshadow the short-term adverse impact of the H-Y effect, but it may have a long-term salubrious effect on graft outcomes.
We restricted our study population to January 1, 1990, through December 31, 2004 , because the completeness of the USRDS data elements that were important to this analysis was less than optimal in 1988 and 1989. The cohort of Gratwohl et al. was assembled from January 1, 1985, through December 31, 2004 . For the exclusion of earlier patients to explain the discordant long-term findings of the two studies, most of the detrimental effect of RF-DM deceased-donor kidney transplants would have to occur in the patients who underwent transplantation from 1985 to 1989. Unfortunately, a subgroup analysis by transplant era was not presented by Gratwohl et al., but our data suggest there may have been improvements in the adjusted risk for graft failure for RF-DM kidney transplants over time. Importantly, differences in clinical practice patterns related to the intensity of immunosuppression may lead to variable expression of the H-Y effect in European versus US patients.
It is interesting to note that, although 1-yr graft survival outcomes slightly favored the USRDS cohort, conditional 10-yr graft survival estimates favored the CTS cohort by up to 10%. 19 Again, this may reflect differences in the study cohorts (e.g., recipient subgroups with inferior graft survival; e.g., black patients are more highly prevalent in the USRDS) and variations in clinical practice patterns (e.g., more widespread use of induction therapy in US patients). It is possible that the presence of numerous competing causes for graft failure may have reduced the likelihood of detecting a modest but significant long-term adverse impact of unfavorable H-Y mismatches in the USRDS cohort.
Other limitations of our study deserve note. First, the actual immune response to H-Y antigens in RF-DM deceased-donor kidney transplants and the impact of different immunotherapy regimens could not be ascertained. Although the H-Y effect is thought to be due to an MHC-restricted cell-mediated immune response, 5, 24, 27 there is also evidence of humoral responses to these antigens. 28 Prospective human studies measuring the H-Y-specific immune response in RF-DM kidney transplants, along with treatment and histologic data, may further elucidate the importance of this effect in the current era of transplantation.
Second, missing data were minimal for the primary exposure and outcomes of interest, but information on confounders were variably complete. Because all covariates were categorized in the main analysis, a missing value indicator was used to account for these incomplete data elements; however, data were reanalyzed after imputation of missing continuous/cate- gorical variables with median/modal values, as well as casewise deletion of observations with any missing data. The results of these sensitivity analyses were consistent with the main findings. Finally, residual confounding is always a concern in the setting of observational studies of registry data. We performed more comprehensive covariate adjustment in sensitivity analyses and found similar results to the main analysis. Although not definitive, this provides some reassurance that important confounders were likely not missed.
In conclusion, after adjustment for recipient and donor gender, female recipients of male deceased-donor kidneys in the United States exhibited a small but significantly increased risk for graft failure and patient mortality in the first year after transplantation as compared with all other recipient-donor gender combinations. This finding may be related to an alloimmune response to H-Y antigens in RF-DM kidney transplants; however, unlike the analysis by Gratwohl et al., 19 a significant increase in long-term risk could not be detected. Future research should examine the potential mechanisms underlying the H-Y effect and potential therapeutic measures to reduce the increased risk for adverse allograft outcomes.
CONCISE METHODS

Study Population
All patients who received a deceased-donor kidney transplant from January 1, 1990, to December 31, 2004 (with follow-up until June 30, 2005) , and were captured in the USRDS were eligible for inclusion in the study. 32 Exclusion criteria were (1) age Ͻ18 yr at the time of transplantation, (2) multiorgan transplant recipients (including kidney-pancreas transplants), and (3) living-donor kidney transplants. Among the 118,230 kidney transplant recipients satisfying the study entry criteria, 353 were excluded because they were missing data on recipient gender, recipient race, donor gender, and/or donor cause of death, resulting in an analytical cohort of 117,877 patients.
Exposures and Outcomes
The primary exposure of interest was female recipients of male deceased-donor kidneys versus all other recipient-donor gender combinations. Recipient and donor gender were also entered as individual covariates into the multivariable models. The outcomes of interest included graft failure, death-censored graft failure, and patient mortality. Graft failure was defined as return to dialysis after transplant failure, preemptive retransplantation, or death with a functioning graft. Death-censored graft failure was similarly defined, except death with a functioning graft was considered a censoring event. All deaths before and after transplant failure were included in the patient mortality outcome. These outcomes were assessed during 1 and 10 yr after transplantation. The 10-yr follow-up analysis was conditional on patient survival at 1 yr after transplantation as per Gratwohl et al. 19 
Confounders
Along with recipient-donor gender status, covariates that may confound the relation between exposure and outcome were incorporated into multivariable models. The covariates chosen for the primary analysis reflected those used by Gratwohl et al. in their report 19 : (1) Recipient factors (age, gender, race, cause of ESRD, peak PRA titer, and regraft status); (2) donor factors (age and gender); and (3) transplant factors (degree of HLA mismatch, cold ischemia time, and transplant era). All continuous variables were grouped into predefined categories for the primary analysis; however, they were also modeled continuously in sensitivity analyses (see the Sensitivity Analysis section).
Missing Data
As previously mentioned, observations with missing data on recipient gender, recipient race, donor gender, and/or donor cause of death were excluded from the analytical cohort because these individuals composed Ͻ1% of the total study population. A missing value indicator was assigned for other covariates with Ն1% missingness in the data set. In sensitivity analyses, the median and modal values for continuous and categorical variables (respectively) were imputed for missing data as described by Gratwohl et al. 19 Finally, case-wise deletion of observations with any missing covariate data were also undertaken to examine the impact of this approach on the relation between exposure and outcome (see Sensitivity Analyses).
Subgroup Analyses
Specific patient subgroups were examined in exploratory analyses to determine whether the relation between exposure and outcome significantly differed across levels of the subgroup variable. These subgroups were specified before the analysis phase of the study. Subgroups of interest included recipient race, donor race, cause of ESRD, peak PRA, HLA mismatches, and transplant era. These variables were chosen on the premise that the effect of H-Y incompatibility may differ across patients of varying genetic makeup, immunologic risk, and cause of kidney disease.
Sensitivity Analyses
More comprehensive adjustment for recipient and donor characteristics was pursued to obtain the most unbiased estimate of the measure of association between exposure and outcome. These models included covariates for time on dialysis, donor race, expanded-criteria donor status, 33 and the recipient/donor weight. Additional analyses that included data from the entire 10-yr follow-up period (i.e., did not condition on 1-yr survival), recipients of first kidney transplants only, and case-wise deletion of observations that were missing any of the covariate data elements used in the primary analysis were performed.
Statistical Analysis
Baseline characteristics were compared across strata defined by recipient-donor gender combinations using the ANOVA or Wilcoxon rank sum test for continuous variables and the 2 test for categorical variables. The survival functions associated with the three primary outcomes were nonparametrically estimated using the Kaplan-Meier product limit method, and differences in these functions were tested using the log-rank statistic. The relation between female recipientmale donor gender status and the main outcomes were subsequently evaluated in multivariable Cox proportional hazards models to ac-count for the influence of confounding variables. The proportional hazards assumption was examined using scaled Schoenfeld residuals and log(cumulative hazard) plots. No important departures from proportionality were detected. Analyses were also performed to determine the existence of effect measure modification across prespecified subgroups. All statistical analyses were performed using Stata/MP 10.1 for Windows (StataCorp, College Station, TX). A two-sided P Ͻ 0.05 was considered statistically significant. The study was approved by the research ethics board of the Toronto General Hospital, University Health Network.
